We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Less is more: role of additional chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal cancer management.
- Authors
Yong Chan Ahn
- Abstract
Concurrent chemoradiation therapy (CCRT) has played the most important and central role in the definitive therapy for the patients with locoregionally advanced stage nasopharynx cancer. The addition of induction chemotherapy (IC) or adjuvant chemotherapy (AC) to CCRT have been widely accepted with the rationale of improving distant control in the clinical practices. This review article investigated the role of IC and AC based on 11 recent meta-analysis publications, and found that the clinical benefits obtained by the additional IC or AC to CCRT, at the cost of the increased risks of more frequent and more severe side effects, seemed not big enough. More intervention is not always better, however, less seems frequently good enough. The author would speculate that 'less is more' and would advocate CCRT alone as the current standard.
- Subjects
NASOPHARYNX cancer; CHEMORADIOTHERAPY; CANCER chemotherapy; ADJUVANT treatment of cancer; DRUG side effects
- Publication
Radiation Oncology Journal, 2019, Vol 37, Issue 2, p67
- ISSN
2234-1900
- Publication type
Article
- DOI
10.3857/roj.2019.00311